Edelman Melbourne has boosted its corporate services offering through a partnership with trans-Tasman investor relations specialist, Intelligentsia.
Headed by former NZBIO Chief Executive, Bronwyn Dilley, Intelligentsia brings extensive IR capabilities as well as experience with high growth, high tech and biotech companies in both Australia and New Zealand.
One of the strengths of the partnership is the combination of a targeted investor relations and stakeholder management offer with a much broader strategic communications capability. For growth companies looking to improve their profile and reputation in international markets ahead of a capital raising, this partnership provides them access to the best of both worlds.
The addition of an investor relations offer is a key step in Edelman’s diversification strategy, and will provide greater strategic capability in the firm’s financial services and M&A practice for both public and private companies.
“Regularly innovating our service offering is an important element of maintaining our client service standards – we bring fresh talent into the mix, along with new skills and new ways of thinking,” said Grant Smith, General Manager of Edelman Melbourne.
Recent IPOs in the biotechnology sector suggest a returning appetite amongst investors for this growth industry. However, the 2011 Edelman Trust Barometer shows the sector has some ground to make up regarding its trust base amongst corporate opinion leaders.
“The uptake of digital media and social networks for investor relations by Australasian companies is well behind global trends, so Edelman’s leadership in digital and social communications around the world offers a significant advantage for growth companies looking to expand,” said Ms. Dilly.
“Sharing our international networks and capabilities provides depth of service and global reach for micro- and small-cap companies looking to expand their global footprint; both from an investor perspective and a customer one,” she added.